FR2244530A1 - - Google Patents

Info

Publication number
FR2244530A1
FR2244530A1 FR7327578A FR7327578A FR2244530A1 FR 2244530 A1 FR2244530 A1 FR 2244530A1 FR 7327578 A FR7327578 A FR 7327578A FR 7327578 A FR7327578 A FR 7327578A FR 2244530 A1 FR2244530 A1 FR 2244530A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7327578A
Other versions
FR2244530B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7327578A priority Critical patent/FR2244530B1/fr
Priority to SE7409158A priority patent/SE7409158L/xx
Priority to US491339A priority patent/US3923985A/en
Priority to AU71659/74A priority patent/AU484644B2/en
Priority to IL45344A priority patent/IL45344A/xx
Priority to ZA00744750A priority patent/ZA744750B/xx
Priority to JP49085268A priority patent/JPS5830319B2/ja
Priority to DK401974A priority patent/DK401974A/da
Priority to BE147004A priority patent/BE818155A/fr
Priority to NL7410093A priority patent/NL7410093A/xx
Priority to CH1034074A priority patent/CH594698A5/xx
Priority to DE2436234A priority patent/DE2436234A1/de
Priority to CA205,774A priority patent/CA1029659A/fr
Priority to IE1605/74A priority patent/IE40163B1/xx
Priority to GB33381/74A priority patent/GB1480763A/en
Publication of FR2244530A1 publication Critical patent/FR2244530A1/fr
Application granted granted Critical
Publication of FR2244530B1 publication Critical patent/FR2244530B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7327578A 1973-07-27 1973-07-27 Expired FR2244530B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR7327578A FR2244530B1 (fr) 1973-07-27 1973-07-27
SE7409158A SE7409158L (sv) 1973-07-27 1974-07-11 Sett att framstella 3,20-dioxo-16Ÿ-metyl-pregna-1,4,9(11)-triener.
US491339A US3923985A (en) 1973-07-27 1974-07-24 Process for the preparation of 16{60 -methyl-{66 {hu 1,4,9(11){b -pregnatrien-3,20-diones and use of the same in treatment of allergies
IL45344A IL45344A (en) 1973-07-27 1974-07-25 Antiallergic compositions containing 21-acyloxy-16 -methyl-pregna-1,4,9(11)-triene-3,20-dione
ZA00744750A ZA744750B (en) 1973-07-27 1974-07-25 16-methyl-pregna-1,4,9 (11)-triene-3,20-diones as medicaments- new processes for the preparation of these products, and pharmaceutical compositions
AU71659/74A AU484644B2 (en) 1973-07-27 1974-07-25 Corticosteroids
DK401974A DK401974A (fr) 1973-07-27 1974-07-26
BE147004A BE818155A (fr) 1973-07-27 1974-07-26 3,20-dioxo 16-methyl pregna-1,4.9(11)-trienes a titre de medicaments nouveau procede de preparation de ces produits et compositions pharmaceutiques
JP49085268A JPS5830319B2 (ja) 1973-07-27 1974-07-26 １６ アルフア − メチルプレグナ −１，４，９ （ １１ ） − トリエン −３，２０− ジオンノ セイゾウホウ
NL7410093A NL7410093A (nl) 1973-07-27 1974-07-26 Werkwijze voor de bereiding van nieuwe farma- ceutische preparaten.
CH1034074A CH594698A5 (fr) 1973-07-27 1974-07-26
DE2436234A DE2436234A1 (de) 1973-07-27 1974-07-26 3,20-dioxo-16alpha-methyl-pregna1,4,9(11)-triene als arzneimittel, neues verfahren zur herstellung dieser verbindungen und pharmazeutische zusammensetzungen
CA205,774A CA1029659A (fr) 1973-07-27 1974-07-26 PROCEDE DE PREPARATION DE 3,20-DIOXO 16.alpha.-METHYL PREGNA 1,4,9(11)TRIENES
IE1605/74A IE40163B1 (en) 1973-07-27 1974-07-29 Pharmaceutical compositions containing steroids
GB33381/74A GB1480763A (en) 1973-07-27 1974-07-29 Pharmaceutical compositions containing steroids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7327578A FR2244530B1 (fr) 1973-07-27 1973-07-27

Publications (2)

Publication Number Publication Date
FR2244530A1 true FR2244530A1 (fr) 1975-04-18
FR2244530B1 FR2244530B1 (fr) 1977-07-01

Family

ID=9123242

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7327578A Expired FR2244530B1 (fr) 1973-07-27 1973-07-27

Country Status (14)

Country Link
US (1) US3923985A (fr)
JP (1) JPS5830319B2 (fr)
BE (1) BE818155A (fr)
CA (1) CA1029659A (fr)
CH (1) CH594698A5 (fr)
DE (1) DE2436234A1 (fr)
DK (1) DK401974A (fr)
FR (1) FR2244530B1 (fr)
GB (1) GB1480763A (fr)
IE (1) IE40163B1 (fr)
IL (1) IL45344A (fr)
NL (1) NL7410093A (fr)
SE (1) SE7409158L (fr)
ZA (1) ZA744750B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2811540A1 (de) * 1977-03-18 1978-09-21 Roussel Uclaf Verfahren zur herstellung eines 16alpha-methylierten steroids

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3656385A1 (fr) * 2008-05-28 2020-05-27 ReveraGen BioPharma, Inc. Modulateurs stéroïdiens non hormonaux de nf-kb pour le traitement d'une maladie
WO2011127048A2 (fr) 2010-04-05 2011-10-13 Validus Biopharma MODULATEURS STÉROÏDES NON HORMONAUX DE NF-ĸB POUR LE TRAITEMENT DE MALADIES
CN102603842B (zh) * 2012-02-20 2013-10-23 湖南新合新生物医药有限公司 醋酸氢化可的松或其类似物的制备方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2944070A (en) * 1958-09-08 1960-07-05 Merck & Co Inc Preparation of 16alpha-lower alkyl steroids
GB935611A (en) * 1958-12-20 1963-08-28 Syntex Sa New cyclopentanophenanthrene derivatives and process for the production thereof
FR1461655A (fr) * 1965-10-28 1966-02-25 Roussel Uclaf Nouveau procédé de préparation d'un dérivé corticostéroïde et produits obtenus dans ce procédé

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2811540A1 (de) * 1977-03-18 1978-09-21 Roussel Uclaf Verfahren zur herstellung eines 16alpha-methylierten steroids

Also Published As

Publication number Publication date
US3923985A (en) 1975-12-02
JPS5041847A (fr) 1975-04-16
GB1480763A (en) 1977-07-27
ZA744750B (en) 1975-08-27
FR2244530B1 (fr) 1977-07-01
IL45344A (en) 1978-08-31
AU7165974A (en) 1976-01-29
JPS5830319B2 (ja) 1983-06-28
DE2436234A1 (de) 1975-02-13
SE7409158L (sv) 1975-01-28
NL7410093A (nl) 1975-01-29
IE40163B1 (en) 1979-03-28
IL45344A0 (en) 1974-10-22
IE40163L (en) 1975-01-27
BE818155A (fr) 1975-01-27
CA1029659A (fr) 1978-04-18
DK401974A (fr) 1975-04-01
CH594698A5 (fr) 1978-01-31

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
FR2244530B1 (fr)
AU472848B2 (fr)
AU476696B2 (fr)
AU466283B2 (fr)
AU461342B2 (fr)
AR196382A1 (fr)
AR210729A1 (fr)
AU471461B2 (fr)
AU447540B2 (fr)
AR196212Q (fr)
AU1891376A (fr)
CH323674A4 (fr)
CH566508A5 (fr)
CH560351A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse